NanoRay Biotech Co., Ltd.

Auger Molecular Therapy (AMT) is a combination therapy with a cancer
DNA-targeting drug and an irradiation
device that generates characteristic X-Ray
at 33 keV, inducing "Auger effect", DNA damage and cancer cell death. AMT is in phase 1 clinical trial, showing excellent
safety and therapeutic efficacy.

• Clinical Trial Collaboration
• Out-Licensing
• Collaborative R&D